Session » Abstracts: RA – Diagnosis, Manifestations, & Outcomes III: Best Day (RA Subpopulations)
- 3:00PM-4:30PM
-
Abstract Number: 1744
Artificial Intelligence: A Novel Tool in the Belt for Improving Rheumatoid Arthritis Outcomes in the National Health Service, United Kingdom
- 3:00PM-4:30PM
-
Abstract Number: 1748
Fracture Incidence Rates in Persons with Rheumatoid Arthritis by Disease Activity Level
- 3:00PM-4:30PM
-
Abstract Number: 1746
Global Recruiting Patterns Are Associated with Placebo Response Rates in Clinical Trials of Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1747
Native Americans Experience Profound Premature Mortality from Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1745
Use of Statins and Its Association with Major Adverse Cardiovascular Outcomes with Tofacitinib versus TNF Inhibitors in a Risk-Enriched Population of Patients with Rheumatoid Arthritis
- 3:00PM-4:30PM
-
Abstract Number: 1743
What Are the Benefits of Treating Rheumatoid Arthritis Patients to Remission After Achieving Low Disease Activity in Clinical Practice?